Daniel Joseph Apel insider trades

Open-market stock purchases and sales by Daniel Joseph Apel, Chief Financial Officer at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 6, 2026.

Recent trades

DateStockTradeValue
Apr 22, 2026ARWR Arrowhead Pharmaceuticals, IncSold$225K
Apr 22, 2026ARWR Arrowhead Pharmaceuticals, IncSold$81.5K
Apr 22, 2026ARWR Arrowhead Pharmaceuticals, IncSold$628K
Jan 6, 2026ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ARWR Arrowhead Pharmaceuticals, Inc: 3 sales, last Apr 22, 2026

Get free alerts when Daniel Joseph Apel files a new trade →